A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome
Clinical trial NCT07600658 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07600658
- Sponsor
- Stanford University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.